Atlas Trials

124I-p5+14 Injection Safety in Subjects With Systemic Amyloidosis

Clinical trial NCT03678259 · COMPLETED

Trial details

NCT number
NCT03678259
Sponsor
University of Tennessee Graduate School of Medicine
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Systemic Amyloidosis
Start date
2018-10-01
Primary completion
2021-10-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.